Patents-Review.com
🔗 Permalink
Assignee profile:

EDISON PHARMACEUTICALS, INC.

City:

Mountain View, California

Country:

United States

Published Applications:

29

Last publication date:

2016-03-17

Patent Grants:

25

Last grant date:

2017-01-17

Top Inventors for applications by EDISON PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to EDISON PHARMACEUTICALS, INC.:

Recent patent applications by EDISON PHARMACEUTICALS, INC.

EDISON PHARMACEUTICALS, INC. based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-03-17 ✅ Patent 9,546,132 granted on 2017-01-17
US20160075638A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #2 | 2016-01-07 ✅ Patent 9,567,279 granted on 2017-02-14
US20160002138A1
Chemistry; metallurgy

Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols

 #3 | 2015-10-22 ✅ Patent 9,486,435 granted on 2016-11-08
US20150297551A1
Human necessities

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

 #4 | 2015-08-27 ✅ Patent 9,399,612 granted on 2016-07-26
US20150239818A1
Chemistry; metallurgy

Treatment of pervasive developmental disorders with redox-active therapeutics

 #5 | 2015-08-06 ✅ Patent 9,629,815 granted on 2017-04-25
US20150218079A1
Chemistry; metallurgy

Benzoquinone derivatives for treating oxidative stress disorders

 #6 | 2014-11-06 ✅ Patent 9,090,576 granted on 2015-07-28
US20140329860A1
Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

 #7 | 2014-10-30 ✅ Patent 9,073,873 granted on 2015-07-07
US20140323509A1
Chemistry; metallurgy

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

 #8 | 2014-09-18 ✅ Patent 9,296,712 granted on 2016-03-29
US20140275054A1
Chemistry; metallurgy

Resorufin derivatives for treatment of oxidative stress disorders

 #9 | 2014-09-18
US20140275045A1
Chemistry; metallurgy

PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS

 #10 | 2014-09-04 ✅ Patent 9,162,957 granted on 2015-10-20
US20140249332A1
Chemistry; metallurgy

Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols

 #11 | 2014-09-04
US20140249160A1
Human necessities

TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS

 #12 | 2014-08-28 ✅ Patent 9,464,016 granted on 2016-10-11
US20140243424A1
Chemistry; metallurgy

Catechol derivatives for treatment of oxidative stress diseases

 #13 | 2014-08-07
US20140221674A1
Chemistry; metallurgy

PROCESS FOR THE PRODUCTION OF ALPHA-TOCOTRIENOL AND DERIVATIVES

 #14 | 2014-07-24 ✅ Patent 8,969,420 granted on 2015-03-03
US20140206772A1
Chemistry; metallurgy

Treatment of pervasive developmental disorders with redox-active therapeutics

 #15 | 2014-02-06 ✅ Patent 9,370,496 granted on 2016-06-21
US20140039065A1
Human necessities

Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones

 #16 | 2014-01-30
US20140031433A1
Human necessities

FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES

 #17 | 2013-10-31 ✅ Patent 9,169,196 granted on 2015-10-27
US20130289034A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #18 | 2013-02-28 ✅ Patent 8,653,144 granted on 2014-02-18
US20130053450A1
Human necessities

Treatment of pervasive developmental disorders with redox-active therapeutics

 #19 | 2012-05-24 ✅ Patent 8,575,369 granted on 2013-11-05
US20120130093A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #20 | 2012-05-17 ✅ Patent 8,519,001 granted on 2013-08-27
US20120122934A1
Chemistry; metallurgy

4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

 #21 | 2012-04-12 ✅ Patent 8,791,155 granted on 2014-07-29
US20120088783A1
Human necessities

Chroman derivatives

 #22 | 2011-11-03 ✅ Patent 10,039,722 granted on 2018-08-07
US20110269776A1
Human necessities

Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells

 #23 | 2011-09-08 ✅ Patent 8,716,486 granted on 2014-05-06
US20110218208A1
Chemistry; metallurgy

2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases

 #24 | 2011-05-26 ✅ Patent 8,716,527 granted on 2014-05-06
US20110124679A1
Chemistry; metallurgy

2-substituted--quinone derivatives for treatment of oxidative stress diseases

 #25 | 2011-02-24 ✅ Patent 8,952,071 granted on 2015-02-10
US20110046219A1
Human necessities

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

 #26 | 2010-04-29 ✅ Patent 8,106,223 granted on 2012-01-31
US20100105930A1
Chemistry; metallurgy

Process for the production of alpha-tocotrienol and derivatives

 #27 | 2010-03-11 ✅ Patent 8,314,153 granted on 2012-11-20
US20100063161A1
Human necessities

Treatment of pervasive developmental disorders with redox-active therapeutics

 #28 | 2007-09-27 ✅ Patent 9,278,085 granted on 2016-03-08
US20070225261A1
Chemistry; metallurgy

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

 #29 | 2006-12-14 ✅ Patent 9,447,006 granted on 2016-09-20
US20060281809A1
Chemistry; metallurgy

Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Also check out Edison Pharmaceuticals, Inc.'s (Mountain View, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

11790 ⎘